Precigen, Inc.
Germantown, MD, US· latest recorded location
PRECIGEN, INC. is named on 33 US grants and 39 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 33
- Published applications
- 39
- Inventors
- 66
- Granted in 2026 so far
- 3
- Most recent grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 1 | 4 |
| 2021 | 7 | 8 |
| 2022 | 3 | 8 |
| 2023 | 5 | 3 |
| 2024 | 9 | 11 |
| 2025 | 5 | 4 |
| 2026 | 3 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 72 documents
- C12NMicroorganisms or enzymes70
- C07KPeptides52
- A61KMedicines and medical preparations48
- A61PTherapeutic uses of medicines44
- C12YEnzymes27
- C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition22
- Y02EClean energy generation and storage22
- G01NInvestigating or analysing materials by determining their chemical or physical properties5
- B01LChemical or physical laboratory apparatus for general use2
- C12MApparatus for enzymology or microbiology2
Recent patents
- Fusion constructs and methods of using thereof11 Aug 2026US 12,703,747 B2
- Electroporation apparatus and method10 Mar 2026US 12,570,945 B2
- CD33 specific chimeric antigen receptors24 Feb 2026US 12,559,536 B2
- Human papillomavirus vaccines and uses of the same2 Sep 2025US 12,404,306 B2
- ROR-1 specific chimeric antigen receptors and uses thereof15 Apr 2025US 12,275,772 B2
- Ror-1 specific chimeric antigen receptors and uses thereof5 Feb 2026US 2026/0035432 A1
- Fusion constructs and methods of using thereof23 Oct 2025US 2025/0325665 A1
- Expression of novel cell tags2 Oct 2025US 2025/0304930 A1
- Hepatitis b vaccines and uses of the same10 Jul 2025US 2025/0223320 A1
- Molecular switches23 Jan 2025US 2025/0027093 A1
Most cited
By later US patents
- Biological production of multi-carbon compounds from methane4US 10,876,137 B22020
- Expression of novel cell tags3US 11,118,168 B22021
- MUC16 specific chimeric antigen receptors and uses thereof2US 11,319,380 B22022
- Polypeptide compositions comprising spacers2US 11,771,718 B22023
- Frataxin expression constructs1US 11,116,852 B22021